Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1989 1
1992 1
2003 3
2004 3
2005 2
2007 2
2008 3
2009 3
2010 4
2011 8
2012 7
2013 11
2014 9
2015 13
2016 11
2017 12
2018 8
2019 7
2020 8
2021 10
2022 10
2023 9
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.
Barratt J, Liew A, Yeo SC, Fernström A, Barbour SJ, Sperati CJ, Villanueva R, Wu MJ, Wang D, Borodovsky A, Badri P, Yureneva E, Bhan I, Cattran D; Cemdisiran Phase 2 Study Investigators and Collaborators. Barratt J, et al. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):452-462. doi: 10.2215/CJN.0000000000000384. Epub 2024 Jan 15. Clin J Am Soc Nephrol. 2024. PMID: 38214599 Clinical Trial.
Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review.
Sellés EG, Pieretti DG, Higuero PP, Del Portillo EG, Macías VM, Domínguez MM, Mateos RF, Campos FL, Díaz-Gavela AA, Ferraris G, Couñago F. Sellés EG, et al. Among authors: macias vm. Future Oncol. 2023 Aug;19(25):1753-1768. doi: 10.2217/fon-2023-0481. Epub 2023 Aug 31. Future Oncol. 2023. PMID: 37650764 Review.
Colorectal Cancer OncoGuia.
Manchon Walsh P, Borràs JM, Ferro T, Espinàs JA; Colorectal Cancer OncoGuia Group. Manchon Walsh P, et al. Clin Transl Oncol. 2010 Mar;12(3):188-210. doi: 10.1007/s12094-010-0489-5. Clin Transl Oncol. 2010. PMID: 20231124 No abstract available.
PRSS8 suppresses colorectal carcinogenesis and metastasis.
Bao Y, Guo Y, Yang Y, Wei X, Zhang S, Zhang Y, Li K, Yuan M, Guo D, Macias V, Zhu X, Zhang W, Yang W. Bao Y, et al. Among authors: macias v. Oncogene. 2019 Jan;38(4):497-517. doi: 10.1038/s41388-018-0453-3. Epub 2018 Aug 16. Oncogene. 2019. PMID: 30115975
Correction to: PRSS8 suppresses colorectal carcinogenesis and metastasis.
Bao Y, Guo Y, Yang Y, Wei X, Zhang S, Zhang Y, Li K, Yuan M, Guo D, Macias V, Zhu X, Zhang W, Yang W. Bao Y, et al. Among authors: macias v. Oncogene. 2021 Mar;40(10):1922-1924. doi: 10.1038/s41388-021-01646-3. Oncogene. 2021. PMID: 33619325 No abstract available.
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
Montgomery H, Hobbs FDR, Padilla F, Arbetter D, Templeton A, Seegobin S, Kim K, Campos JAS, Arends RH, Brodek BH, Brooks D, Garbes P, Jimenez J, Koh GCKW, Padilla KW, Streicher K, Viani RM, Alagappan V, Pangalos MN, Esser MT; TACKLE study group. Montgomery H, et al. Lancet Respir Med. 2022 Oct;10(10):985-996. doi: 10.1016/S2213-2600(22)00180-1. Epub 2022 Jun 7. Lancet Respir Med. 2022. PMID: 35688164 Free PMC article. Clinical Trial.
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.
López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C. López Torrecilla J, et al. Among authors: macias v. Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):259-72. doi: 10.1016/j.rpor.2015.04.003. Epub 2015 May 30. Rep Pract Oncol Radiother. 2015. PMID: 26109913 Free PMC article. Review.
134 results